These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30916600)

  • 21. The future of rotavirus vaccines.
    Offit PA
    Semin Pediatr Infect Dis; 2002 Jul; 13(3):190-5. PubMed ID: 12199615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa.
    Steele AD; Madhi SA; Louw CE; Bos P; Tumbo JM; Werner CM; Bicer C; De Vos B; Delem A; Han HH
    Pediatr Infect Dis J; 2011 Feb; 30(2):125-30. PubMed ID: 20842070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of the oral pentavalent rotavirus vaccine in Mali.
    Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM
    Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.
    Chen MY; Kirkwood CD; Bines J; Cowley D; Pavlic D; Lee KJ; Orsini F; Watts E; Barnes G; Danchin M
    Hum Vaccin Immunother; 2017 May; 13(5):1126-1135. PubMed ID: 28059609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.
    Burnett E; Lopman BA; Parashar UD
    Vaccine; 2017 Dec; 35(51):7198-7203. PubMed ID: 29169893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh.
    Zaman K; Yunus M; El Arifeen S; Azim T; Faruque AS; Huq E; Hossain I; Luby SP; Victor JC; Dallas MJ; Lewis KD; Rivers SB; Steele AD; Neuzil KM; Ciarlet M; Sack DA
    Vaccine; 2012 Apr; 30 Suppl 1():A94-100. PubMed ID: 22520143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pentavalent rotavirus vaccine, RotaTeq.
    Matson DO
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Live attenuated human rotavirus vaccine, Rotarix.
    Bernstein DI
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants.
    Narang A; Bose A; Pandit AN; Dutta P; Kang G; Bhattacharya SK; Datta SK; Suryakiran PV; Delem A; Han HH; Bock HL
    Hum Vaccin; 2009 Jun; 5(6):414-9. PubMed ID: 19276664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral live attenuated human rotavirus vaccine (Rotarix™) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children.
    Justino MC; Araújo EC; van Doorn LJ; Oliveira CS; Gabbay YB; Mascarenhas JD; Miranda YS; Guerra Sde F; Silva VB; Linhares AC
    Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):846-53. PubMed ID: 23147138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Parashar UD; Alexander JP; Glass RI;
    MMWR Recomm Rep; 2006 Aug; 55(RR-12):1-13. PubMed ID: 16902398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review.
    Nakagomi O; Iturriza-Gomara M; Nakagomi T; Cunliffe NA
    Expert Opin Biol Ther; 2013 Nov; 13(11):1613-21. PubMed ID: 24088009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of different dosing schedules of the human live attenuate rotavirus vaccine (RV1) in infants and children: a meta-analysis.
    Dai X; Bai R; Jian M; Ji Z; Ding Z; Wang F; Bi Y; Manzamaesso A; Chen T; Luo L; Liu A; Bao F
    Hum Vaccin Immunother; 2019; 15(6):1228-1236. PubMed ID: 30346870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WHO informal consultation on quality, safety and efficacy specifications for live attenuated rotavirus vaccines Mexico City, Mexico, 8-9 February 2005.
    Wood D;
    Vaccine; 2005 Dec; 23(48-49):5478-87. PubMed ID: 16129525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.
    Salinas B; Pérez Schael I; Linhares AC; Ruiz Palacios GM; Guerrero ML; Yarzábal JP; Cervantes Y; Costa Clemens S; Damaso S; Hardt K; De Vos B
    Pediatr Infect Dis J; 2005 Sep; 24(9):807-16. PubMed ID: 16148848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccines in Children Exposed to Biological Agents In Utero and/or During Breastfeeding: Are They Effective and Safe?
    Gisbert JP; Chaparro M
    J Crohns Colitis; 2023 Jun; 17(6):995-1009. PubMed ID: 36652274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial.
    Valéa I; Adjei S; Usuf E; Traore O; Ansong D; Tinto H; Owusu Boateng H; Leach A; Mwinessobaonfou Some A; Buabeng P; Vekemans J; Nana LA; Kotey A; Vandoolaeghe P; Ouedraogo F; Sambian D; Lievens M; Tahita MC; Rettig T; Jongert E; Lompo P; Idriss A; Borys D; Ouedraogo S; Prempeh F; Habib MA; Schuerman L; Sorgho H; Agbenyega T
    Hum Vaccin Immunother; 2018 Jun; 14(6):1489-1500. PubMed ID: 29630438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine.
    Dennehy PH; Brady RC; Halperin SA; Ward RL; Alvey JC; Fischer FH; Innis BL; Rathfon H; Schuind A; De Vos B;
    Pediatr Infect Dis J; 2005 Jun; 24(6):481-8. PubMed ID: 15933555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.
    Thrall S; Doll MK; Nhan C; Gonzales M; Perreault T; Lamer P; Quach C
    Vaccine; 2015 Sep; 33(39):5095-102. PubMed ID: 26296493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.